A veteran biostatistician on the planning document and the dose-selection shortcut that quietly decide whether trials succeed.
- The Vendor Questions Most Clinical Tech Buyers Forget To Ask
- AI In Clinical Trials: Stop Hyping It, Start Proving It
- What AI Can't Fix In Decentralized Clinical Trial Data
- Decentralized Trials Promised Less Burden. Did They Deliver?
- Wireless Connectivity Is A Data Integrity Issue, Not IT
- Why Clinical AI Validation Needs Portability Testing Beyond A Single Accuracy Score
- The Synchronization Problem Clinical Research Isn't Watching
- Why Ophthalmology Trials Are Clinical Research's Toughest Tech Test
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Revolutionizing Clinical Trial Feasibility
Transform feasibility into a continuous, data-driven process, that helps sponsors streamline trial planning, maintain timelines, and deliver therapies to patients faster.
-
eCOA Risk Management In The Digital Age
Regulators across the globe are urging the industry to strengthen their data integrity practices. This article addresses the additional considerations that go hand in hand with the increased reliance on eSource data and the expansion of the electronic systems in clinical trials.
-
Preparing Studies With eConsent For IRB Approval
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
How AI And ML Can Transform Clinical Trial Conduct
There’s no doubt that 2023 will be remembered as the year that artificial intelligence and machine learning became mainstream. Gain an overview of the uses of AI and ML in clinical conduct.
-
How Heron Therapeutics Sped Up Database Creation
Electronic data capture (EDC) is straightforward, in theory. However, not every EDC is purpose-designed for ease of use by study teams, and some are easier to use and more intuitive than others.
-
The Impact Of Automation In The Monitoring And Reporting Process
As clinical trial costs rise and ROIs decline, research teams are turning to automation to streamline monitoring and reporting processes without compromising data quality or regulatory compliance.
-
A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients
Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.
-
Cagey Sponsors, Defensive Vendors: Observations On How Transparency Breaks Down
Discover how hidden operational uncertainties trigger defensive pricing and scope disputes—and how early transparency builds stable, high-performing research partnerships.
-
Oncology Preferences From Patients And Caregivers On Trial Tech
Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.
-
Revolutionizing Pediatric Clinical Trials With ePRO And eConsent
Digital tools like ePRO and eConsent are essential in addressing pediatric trial challenges such as the diverse participant ages and family involvement, which impact retention and data quality.
RECENT NEWSLETTERS
- 09.05.26 -- Best Of August: AI, FDA RWE, And Trial Data Risks
- 09.03.26 -- AI, APIs, and eConsent Are Exposing Trial Workflow Gaps
- 08.27.26 -- Patient Data Breaks Down When Trial Systems Miss Reality
- 08.20.26 -- Clinical AI Validation, Trial Handoffs, And Smarter Study Builds
- 08.13.26 -- AI Urgency, Site-Sponsor Gaps, And Data That Saves Lives